Skip to main content
. 2018 Apr 11;12(Suppl 1):37. doi: 10.1186/s12918-018-0527-4

Table 6.

The predicted ncRNAs related to the six diseases examined in this study

Disease ncRNA Evidence (PMID)
Breast
Neoplasms
H19 15985428;27540977;9811352;24780616
Breast
Neoplasms
PVT1 17908964;10485452;23907597
Breast
Neoplasms
SRA1 17710122;26460974
Breast
Neoplasms
WRAP53 27525856;15736456
Carcinoma, Hepatocellular H19 9570364
Carcinoma, Hepatocellular PCNA-AS1 24704293
Carcinoma, Hepatocellular WRAP53 23836507
Lung
Neoplasms
HOTAIR 25010625;22088988
Lung
Neoplasms
MALAT1 23243023;26490983
Lung
Neoplasms
PVT1 25400777
Lung
Neoplasms
XIST 26339353
 Prostatic Neoplasms CDKN2B-AS1 27197191;24988946
 Prostatic Neoplasms H19 19513555;25895025
 Prostatic Neoplasms HOTAIR 26411689
 Prostatic Neoplasms MALAT1 23845456
 Prostatic Neoplasms PCAT1 21804560
 Prostatic Neoplasms SRA1 16607388
 Prostatic Neoplasms XIST 16261845
 Stomach Neoplasms CDKN2B-AS1 24810364;26187665
 Stomach Neoplasms HOTAIR 25063030;23898077
 Stomach Neoplasms MALAT1 24857172
Urinary Bladder Neoplasms H19 23354591
Urinary Bladder Neoplasms WRAP53 27912092

The predicted ncRNAs related to lung cancer, liver cancer, breast cancer, urinary bladder neoplasms, prostatic neoplasms and stomach neoplasms based upon our method. Each research article reporting on a specific ncRNA is shown with a unique ID (PMID) by PubMed